MedCity Pivot Podcast: An interview with Bari Kowal, vice president of global clinical operations, Regeneron

Regeneron Pharmaceuticals, one of the businesses taking up Covid-19 has been making information just lately — both very good and not so much. So it was fortuitous that I had the prospect to speak with the pinnacle of its clinical operations.

Within the third episode of Pivot, Bari Kowal, Regeneron’s vice president of global clinical operations, gives us perception into the pharma firm’s efforts to halt the march of the novel coronavirus. However equally importantly, she displays on the broad adjustments that should be instituted to overtake clinical trials whereas additionally working to decrease costs and enhance entry.

Sharing is caring!

Leave a Reply

Your email address will not be published. Required fields are marked *